LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Home・Elenco Azioni・Stryker Corp

Stryker Corp

Chiusa

SettoreSettore sanitario

306.35 0.28

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

303.12

Massimo

310.87

Metriche Chiave
By Trading Economics
Entrata	-104M 745M
Vendite	-1.2B 6B
P/E Media del settore	32.668 51.415
EPS	1.93
Rendimento da dividendi	1.21
Margine di Profitto	12.375
Dipendenti	56,000
EBITDA	-478M 1.2B

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+29.65% upside

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	1.21% 2.34%
Utili prossimi	30 lug 2026
Prossima data del Dividendo	30 lug 2026
Prossima data del' Ex Dividendo	29 giu 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-18B 108B
Apertura precedente	306.07
Chiusura precedente	306.35

Notizie sul Sentiment di mercato

By Acuity

35%

65%

108 / 345 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

373.92 / 383.99 Supporto e resistenza

Stryker Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

30 apr 2026, 20:41 UTC

Utili

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12 mar 2026, 21:42 UTC

Principali Notizie su Eventi

Stryker Says Cyberattack Disruption Is Continuing

11 mar 2026, 19:18 UTC

I principali Market Mover

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29 gen 2026, 22:05 UTC

Utili

Stryker Logs Higher 4Q Profit On Sales Gains

30 ott 2025, 20:36 UTC

Utili

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30 apr 2026, 20:06 UTC

Utili

Stryker 1Q Organic Net Sales Up 2.4%

30 apr 2026, 20:06 UTC

Utili

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q Adj EPS $2.60 >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q EPS $1.93 >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q Net $745M >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q Sales $6.02B >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q Net $745M >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q Adj EPS $2.60 >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q EPS $1.93 >SYK

30 apr 2026, 20:05 UTC

Utili

Stryker 1Q Sales $6B >SYK

9 apr 2026, 20:55 UTC

Utili

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 apr 2026, 20:55 UTC

Utili

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 apr 2026, 20:55 UTC

Utili

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16 mar 2026, 00:00 UTC

Principali Notizie su Eventi

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30 gen 2026, 17:03 UTC

Discorsi di Mercato

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29 gen 2026, 21:07 UTC

Utili

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29 gen 2026, 21:05 UTC

Utili

Stryker 4Q Adj EPS $4.47 >SYK

5 nov 2025, 19:38 UTC

Utili

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 nov 2025, 17:00 UTC

Utili

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30 ott 2025, 20:21 UTC

Utili

Stryker Lifts FY Sales View After 3Q Revenue Rises

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Adj EPS $3.19 >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q EPS $2.22 >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Sales $6.1B >SYK

30 ott 2025, 20:05 UTC

Utili

Stryker 3Q Net $859M >SYK

Confronto tra pari

Modifica del prezzo

Stryker Corp Previsione

Obiettivo di Prezzo

By TipRanks

29.65% in crescita

Previsioni per 12 mesi

Media 391.67 USD 29.65%

Alto 465 USD

Basso 315 USD

Basato su 23 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stryker Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

23 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 23 che hanno fornito valutazioni azionarie a Stryker Corp - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

373.92 / 383.99Supporto e resistenza

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

108 / 345 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.